Burke & Herbert Financial Services vs Carter Bankshares
BHRB and CARE side by side, both in commercial banks. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How BHRB and CARE compare
Burke & Herbert Financial Services is the larger company, worth 2.2 times as much as Carter Bankshares ($1.4B against $650M).
On earnings, Carter Bankshares is cheaper: it trades at 5.0× trailing earnings, against 11.8× for Burke & Herbert Financial Services.
Carter Bankshares grew revenue faster over the last twelve months (76.9% versus 17.7% for Burke & Herbert Financial Services).
Carter Bankshares keeps more of each dollar of sales as profit, with a net margin of 50.0% compared with 26.0% at Burke & Herbert Financial Services.
Both pay dividends: Burke & Herbert Financial Services yields 3.9% and Carter Bankshares 1.0%.
Burke & Herbert Financial Services scores higher on the StockData Score (17 against 15 for Carter Bankshares), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | BHRB | CARE |
|---|---|---|
| Size and price | ||
| Market cap | $1.4B | $650M |
| Share price | $71.29 | $29.32 |
| Change, 1 year | 15.0% | 66.8% |
| Change, 5 years | 29.5% | 89.8% |
| Beta (5Y) | 0.49 | 0.60 |
| Employees | 832 | 687 |
| StockData Score | ||
| Total score | 17 (better) | 15 |
| Valuation score | 4 | 6 (better) |
| Growth score | 2 (better) | 1 |
| Performance score | 1 | 3 (better) |
| Health score | 5 (better) | 4 |
| Dividend score | 5 (better) | 1 |
| Valuation | ||
| P/E | 11.8× | 5.0× (better) |
| P/S | 3.6× | 2.5× (better) |
| P/B | 1.2× | 1.2× (better) |
| P/FCF | 15.2× | 13.4× (better) |
| PEG | 1.25 | – |
| FCF yield | 6.6% | 7.5% (better) |
| Fair value | $73.96 | $50.89 |
| Margin of safety | 3.6% | 42.4% (better) |
| Growth | ||
| Revenue growth (TTM) | 17.7% | 76.9% (better) |
| Revenue growth, 5Y average | – | 2.5% |
| Net income growth (TTM) | −3.2% | 320% (better) |
| EPS growth (TTM) | −14.2% | 335% (better) |
| Profitability | ||
| Net margin | 26.0% | 50.0% (better) |
| FCF margin | 23.8% (better) | 18.5% |
| Return on equity | 10.5% | 27.9% (better) |
| Financial health | ||
| Debt / equity | 0.46 | – |
| Altman Z-score | 0.19 | 0.29 (better) |
| Piotroski F-score | 4 | 7 (better) |
| Dividends and buybacks | ||
| Dividend yield | 3.9% (better) | 1.0% |
| Payout ratio | 38.3% | – |
| Years of dividend growth | 2 | – |
| Buyback yield | 0.00% | – |
| Shareholder yield | 3.9% (better) | 1.0% |
| Ownership | ||
| Held by institutions | 44.7% | 65.5% |
| Held by insiders | 9.6% | 4.4% |
| Insider net buying, 12 months | $580K (better) | −$253K |
| Short interest, % of float | 4.4% | 11.4% |
Go deeper
- BHRB stock overview
- BHRB income statement
- BHRB valuation and score
- CARE stock overview
- CARE income statement
- CARE valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.